SCHEMBL6137625

SCHEMBL6137625

O=C1Nc2cc(CCCO)ccc2C2CCCC12F

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 6/20 0.40
NOS1 P29475 6/20 0.40
NOS2 P35228 6/20 0.40
CHEK1 O14757 1/20 0.32
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
P2RY12 Q9H244 1/20 0.31
CYP4F2 P78329 1/20 0.31
CYP4A11 Q02928 1/20 0.31
P2RX7 Q99572 1/20 0.30
BCHE P06276 1/20 0.30
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137525 0.93 NOS3 (0.41) NOS3NOS1NOS2
SCHEMBL6137774 0.88 NOS3 (0.39) NOS3NOS1NOS2
SCHEMBL6137346 0.78 NOS3 (0.66) NOS3NOS1NOS2ACHE
SCHEMBL7171088 0.76 HTT (0.37) NOS3NOS1NOS2
SCHEMBL6137714 0.75 NOS3 (0.40) NOS3NOS1NOS2
SCHEMBL7180340 0.75 NOS3 (0.32) NOS3NOS1NOS2
SCHEMBL6137765 0.73 NOS3 (0.40) NOS3NOS1NOS2
SCHEMBL6137662 0.73 NOS3 (0.34) NOS3NOS1NOS2
SCHEMBL6137634 0.73 NOS3 (0.48) NOS3NOS1NOS2
SCHEMBL6137586 0.72 PARP1 (0.34) NOS3NOS1NOS2CHEK1PDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed